Fused heterocyclic kinase inhibitors

In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.

Saved in:
Bibliographic Details
Main Authors ZHEN-WEI CAI, ROBERT M. BORZILLERI, WAYNE VACCARO, XIAO TAO CHEN, TRAM N. HUYNH, ZHONG CHEN, KYOUNG S. KIM
Format Patent
LanguageEnglish
Published 12.01.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
Bibliography:Application Number: AU20050260056